CompaniesAltus Pharmaceuticals

Altus Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (5)

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

406

By Phase

PHASE1/PHASE2: 2PHASE3: 1PHASE2: 2

By Status

UNKNOWN: 3COMPLETED: 2

Clinical Trials Pipeline5 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT04988217Collaborator

Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)

PHASE1/PHASE2Completed

173 participants

Started: Sep 15, 2021 · Completed: Jul 28, 2022

NCT04143789Lead Sponsor

Evaluation of AP-002 in Patients With Solid Tumors

PHASE1/PHASE2Unknown

61 participants

Started: Sep 27, 2019 · Completed: Apr 30, 2021

NCT00944268Lead Sponsor

Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety

124 participants

Started: Sep 30, 2009 · Completed: Jan 31, 2010

NCT00837863Lead Sponsor

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

36 participants

Started: Mar 31, 2009

NCT00297713Lead Sponsor

Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

PHASE2Completed

12 participants

Started: Jul 31, 2005 · Completed: Jun 30, 2006

Funding History (20)

8-K

Nov 12, 2009

8-K

Nov 4, 2009

8-K

Oct 8, 2009

8-K

Sep 18, 2009

8-K

Sep 14, 2009

8-K

Sep 9, 2009

8-K

Aug 21, 2009

8-K

Aug 17, 2009

8-K

Aug 11, 2009

8-K

Jul 6, 2009

Related Companies

Althea

acquired